Replies to post #20708 on Medizone Intl. (fka MZEIQ)

[moanie]

WIV, I agree, I personally think the bed bugs are the thing to attack first it should creat an income faster. Not only killing the little critters but also kills the unseen killers with the 6 log kill rates. For example someone with a virus leaving a trail of infected areas such as door knobs etc. and let the good doctors persue the other areas. 2012 is gonna real interesting for MEDIZONE! moanie

[bigmoonshot]

It's an interesting premise regarding 3M in acquiring ROL to get into the pest control business with Medizone being the crown jewel in its future business plans. 3M definitely has the money to make the acquisitions and does have an infection control division to take advantage of AsepticSure technology.
A company that has popped up on my radar screen recently is Ecolab. http://www.ecolab.com

Here is the business summary:
Ecolab Inc. engages in the development, manufacture, sale, and service of products that clean, sanitize, and promote food safety and infection prevention. It delivers cleaning and sanitizing programs and services to meet the needs of customers in the foodservice, food and beverage processing, hospitality, healthcare, government and education, retail, textile care, commercial facilities management, and vehicle wash sectors. The company serves customers in approximately 160 countries across North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Ecolab Inc. was founded in 1923 and is headquartered in St. Paul, Minnesota.

Furthermore, Ecolab also has a pest control division as well although not as well known as Orkin. This company appears to be an excellent synergistic fit for Medizone. However, I do not believe that they have enough cash to make an acquisition of MZEI (i.e. ...at least not in my greedy estimate, lol) but the two companies can merge with an exchange for shares. This would help shareholders in terms of tax liability as opposed to an all cash acquisition. It's interesting to note that 3M and Ecolab are headquartered in the same city of St. Paul, Minnesota. Maybe these 2 innovative companies can merge together and acquire Medizone together?

On another topic, I've seen on a number of your posts where you state the immediate need for an investment bank. Is this more of a solicitation for business for your investment firm or more so to appease the impatient shareholder in all of us? Ed Marshall has already stated that he would look into the hiring of an investment bank down the road. I mean no offense when I ask this question. From your perspective, it appears that time is of the essence in the hiring of an investment bank. This I do not understand and I defer to your experience as an investment banker to explain this need now. From my perspective as a large shareholder, I see the company with limited resources where the hiring of an investment banker would mean millions of shares given to Mammoth in this funding purpose for market research with future stock dilution at this ridiculously low stock price. I see the share price going further up with the bedbug news along with possible preliminary sales after FIME. Let's gauge this interest at FIME first before spending this money which may go to use for near production of AsepticSure machines. I can also see the issuing of patents before year end which will add value to the company along with the share price. In short, there is pending news in the near future that would raise the stock price to help reduce the stock dilution. I feel that the wall at 24 cents was due to Mammoth selling their shares for Medizone's earlier drawdown for funds. I don’t negate the need for the hiring of an investment bank down the road especially when the stock price is much higher than it is right now.

Also, I was wondering about the likelihood of an interested buyer of Medizone in forking out the money instead to pay for market research in terms of the market potential of AsepticSure. I feel that the myriad of applications in huge markets will entice a potential buyer(s) to pay for the market research before possible acquisition with a moratorium of understanding between the 2 companies. If the possible acquiring company has done everything in good faith, I don't see why they couldn't share the information as both sides would want fair value.

I thank you for your consistently thought provoking posts.